Announcement Date:  January 6, 2026

Global Regulatory Partners GK (“GRP”) is pleased to announce the publication of our 2026 New Year Message from Dr. Suzan Davis, President & CEO. In this message, Dr. Davis shares GRP’s outlook for the year ahead and reaffirms our commitment to accelerating patient access to innovative healthcare products in Japan, while continuing to support our partners, healthcare professionals, and the Japanese healthcare community. As GRP marks its 10th anniversary in Japan, we invite you to click HERE to read the full message on our website.

ABOUT GLOBAL REGULATORY PARTNERS

Global Regulatory Partners (GRP) is a leading provider of integrated regulatory affairs, compliance, and commercialization solutions for pharmaceutical, biotechnology, and medical device companies entering Japan. By serving as a Market Authorization Holder (MAH) in Japan, GRP simplifies market entry, accelerates regulatory approval timelines, and enables faster patient access to innovative healthcare products throughout the product lifecycle.

To learn more about Global Regulatory Partners and its services in Japan, visit: